Gene-RADAR technology to diagnose infections, cancer, and improve fitness
Dr. Anita Goel has developed new point-of-care diagnostic technology that provides fast results, and can be used in rapid cancer and infections diagnosis
How can people use Gene-RADAR technology today? We’ve just received our first FDA approval for Zika tests on the Gene-RADAR platform. And if you recall, in the last mosquito season in Miami pregnant women were waiting anywhere from one to five weeks to get an answer as to whether they have Zika. Because they had to take their samples, ship it to a centralized CDC-approved state testing lab and wait that much time. And there was some backlog and the running of the samples – until they could find out whether they had Zika or not. Now, if you’re pregnant and you’re trying to make a decision about the pregnancy, that could be a very long period of time to be waiting. With Gene-RADAR first generation system that we have just received our FDA approval, it enables you to essentially run the test in about an hour. And our longer-term vision is you would be able to do this kind of testing in real time, out in the field. Our first system is designed to work in a CLIA lab or in a hospital’s CLIA lab, but eventually the vision is to bring this out to the doctor’s offices, people’s homes, rural remote villages in the developing world. So we’re taking the ability of diagnosing disease outside of a centralized lab and an infrastructure, and bringing it out into a mobile device that can fit in the palm of your hand and be used in a decentralized setting, doctors offices, people’s homes, rural villages. So you can have information about your own health on demand. The traditional kind of testing for these infectious diseases can cost a few hundred dollars per test, and it can take a few weeks sometimes by the time you send your samples in and you get your results back. With our kind of test we’re eventually trying to make it very affordable.